Mary Macri
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Co-authors
- Toni Ricciardi (20 shared papers)Ralph Venhaus (20 shared papers)Aileen Ryan (20 shared papers)Paul Schwarzenberger (15 shared papers)Andrew J. Park (4 shared papers)David A. Reardon (6 shared papers)Hui Gan (6 shared papers)Timothy F. Cloughesy (5 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Neuro-Oncology (3 papers)Cancer Immunology Research (3 papers)Annals of Oncology (1 paper)Gynecologic Oncology (1 paper)
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
Mary Macri
20 papers receiving 231 citations
Peers
Comparison fields: 5 of 29
- Genetics 87
- Oncology 155
- Immunology 97
- Pulmonary and Respiratory Medicine 41
- Biotechnology 12
Countries citing papers authored by Mary Macri
This map shows the geographic impact of Mary Macri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Macri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Macri more than expected).
Fields of papers citing papers by Mary Macri
This network shows the impact of papers produced by Mary Macri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Macri. The network helps show where Mary Macri may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary Macri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 45 | |
| 2 | 2017 | 43 | |
| 3 | 2017 | 24 | |
| 4 | 2021 | 21 | |
| 5 | 2018 | 16 | |
| 6 | 2018 | 14 | |
| 7 | 2019 | 12 | |
| 8 | 2016 | 9 | |
| 9 | 2017 | 8 | |
| 10 | 2018 | 7 | |
| 11 | 2020 | 6 | |
| 12 | 2020 | 6 | |
| 13 | 2016 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2017 | 4 | |
| 16 | 2017 | 3 | |
| 17 | 2023 | 2 | |
| 18 | 2021 | 2 | |
| 19 | 2019 | 1 | |
| 20 | 2019 | 1 |
About Mary Macri
Mary Macri is a scholar working on Oncology, Genetics, Biotechnology, Immunology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 235 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Cancer Research and Treatments (6 papers), Immunotherapy and Immune Responses (5 papers), Glioma Diagnosis and Treatment (5 papers), Peptidase Inhibition and Analysis (3 papers), CAR-T cell therapy research (3 papers), Virus-based gene therapy research (3 papers) and Ovarian cancer diagnosis and treatment (2 papers). The work is most often cited by research in Genetics (87 citations), Oncology (155 citations), Immunology (97 citations), Pulmonary and Respiratory Medicine (41 citations) and Biotechnology (12 citations). Mary Macri has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Toni Ricciardi, Ralph Venhaus, Aileen Ryan, Paul Schwarzenberger, Andrew J. Park, David A. Reardon, Hui Gan, Timothy F. Cloughesy, Gavin P. Dunn and Thomas Kaley. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Cancer Immunology Research, Annals of Oncology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.